Contrary to the above cited studies, we did not detect statistically significant impact of UBE2C expression on the survival of the ESCC patients included in our study, neither association between UBE2C expression and any of the evaluated clinicopathological features. The gene discussed is UBE2C; the disease is esophageal squamous cell carcinoma.